| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.099 | 0.06 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |